Access the full text.
Sign up today, get DeepDyve free for 14 days.
(1991)
GOA KL . Levocabastine . A review of its pharmacological properties and Therapeutic potential in allergic rhinitis and conjunctivitis
M. Friedlaender (1983)
Corticosteroid therapy of ocular inflammation.International ophthalmology clinics, 23 1
(1991)
Current concepts in ocular allergy. A n n Allergy
W. Busse (1988)
New directions and dimensions in the treatment of allergic rhinitis.The Journal of allergy and clinical immunology, 82 5 Pt 2
(1991)
A review of its pharmacological properties and Therapeutic potential in allergic rhinitis and conjunctivitis
Effect O f the HI-835-6 1
M. Janssens, G. Bussche (1991)
Levocabastine: an effective topical treatment of allergic rhinoconjunctivitisClinical & Experimental Allergy, 21
S. Croner, N. Kjetlman (1990)
Development of atopic disease in relation to family history and cord blood IgE levelsPediatric Allergy and Immunology, 1
(1992)
placebo-controlled study of the effect of intranasal budesonide i n the treatment of children with seasonal rh initis
F. Njaa, T. Baekken, D. Bjaamer, J. Holme, F. Korsrud, O. Woxen, A. Olsen (1992)
Levocabastine compared with sodium cromoglygate eyedrops in children with both birch and grass pollen allergyPediatric Allergy and Immunology, 3
C. Möller, L. Blychert (1990)
Levocabastine eyedrops in comparison with cromoglycate in the treatment of conjunctivitis in children with birch pollinosisPediatric Allergy and Immunology, 1
(1992)
Levocabactine compared with sodium cromoglycate eyedrops in children with both birch and grsss pollen allergy
(1983)
Inhibition of histamine-induced nasal symptoms by the H,-receptor antagonist chlorpheniramine
J. Kirkegaard, Claus Secher, N. Mygind (1982)
Effect of the H1 Antihistamine Chlorpheniramine Maleate on Histamine‐Induced Symptoms in the Human ConjunctivaAllergy, 37
K. Dechant, Karen Goa (2012)
LevocabastineDrugs, 41
(1989)
HI - receptor antagonists : clinlcal pharniacol - ogy and therapeutics
J. Kemp (1992)
Antihistamines--is there anything safe to prescribe?Annals of allergy, 69 4
(1992)
A double - blind . placebo - controlled study of the effect of intranasal budesonide i n the treatment of children with seasonal rh in - itis
Delafuente Delafuente, Davis Davis, Davis Davis (1989)
Pharmacotherapy of allergic rhinitisClin Pharm, 8
F. Simons (1989)
H1-receptor antagonists: clinical pharmacology and therapeutics.The Journal of allergy and clinical immunology, 84 6 Pt 1
M. Friedlaender (1991)
Current concepts in ocular allergy.Annals of allergy, 67 1
J. Kirkegaard, C. Secher, P. Borum, N. Mygind (1983)
Inhibition of histamine-induced nasal symptoms by the H1 antihistamine chlorpheniramine maleate: demonstration of topical effect.British journal of diseases of the chest, 77 2
S. Tomiyama, M. Ohnishi, M. Okuda (1993)
The Dose and Duration of Effect of Levocabastine, A New Topical H1 Antagonist, on Nasal Provocation Reaction to AllergenAmerican Journal of Rhinology & Allergy, 7
O. Wolthers, Bent Jørgensen, S. Pedersen (1992)
A double‐blind, placebo‐controlled study of the effect of intranasal budesonide in the treatment of children with seasonal rhinitisActa Pædiatrica, 81
Children (n = 110) with seasonal allergic rhinoconjunctivitis were randomized to receive either twice daily 0.05% levocabastine eye drops and nasal spray plus twice daily topical placebos or 2% sodium cromoglycate eye drops and nasal spray four times daily for a period of 4 weeks. Patients were required to use the nasal sprays as directed and the eye drops only when required. The results obtained suggest that topical levocabastine is at least as effective as sodium cromoglycate for the treatment of this condition. After 2 weeks treatment the effect of therapy on nasal symptoms was considered to be excellent or good in 72% of levocabastine‐treated patients and 54% of patients on sodium cromoglycate (p = 0.009), with corresponding values for ocular symptoms of 81% and 57% in the two groups, respectively (p < 0.05). Investigator assessments also revealed that the severity of sneezing and lacrimation were significantly lower in the levocabastine group at this time (p < 0.05). After 4 weeks of treatment, patient diary data revealed that levocabastine was at least as effective as sodium cromoglycate with intergroup differences attaining statistical significance in favor of the topical antihistamine for nasal congestion (p < 0.05). Both agents were well‐tolerated with no significant differences in the incidence or type of adverse reactions in the two treatment groups.
Pediatric Allergy and Immunology – Wiley
Published: Nov 1, 1994
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.